C08004-2018

SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)
Nov 28, 2018
2. SEC Identification Number
443
3. BIR Tax Identification No.
000-444-210-000
4. Exact name of issuer as specified in its charter
China Banking Corporation
5. Province, country or other jurisdiction of incorporation
Philippines
6. Industry Classification Code(SEC Use Only)
7. Address of principal office
China Bank Building, 8745 Paseo de Roxas corner Villar Street, Makati City Postal Code 1226
8. Issuer's telephone number, including area code
885-5555
9. Former name or former address, if changed since last report
N.A.
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common 2,685,899,812
11. Indicate the item numbers reported herein
Item 9

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

China Banking CorporationCHIB

PSE Disclosure Form 4-30 - Material Information/Transactions References: SRC Rule 17 (SEC Form 17-C) and
Sections 4.1 and 4.4 of the Revised Disclosure Rules

Subject of the Disclosure

Capital Infusion in Manulife China Bank Life Assurance Corporation

Background/Description of the Disclosure

Please be informed that during the regular meeting held this afternoon, 28 November 2018, subject to confirmation of the Board, the Executive Committee of the Bank approved an additional capital infusion in the amount P40 Million in Manulife China Bank Life Assurance Corporation (MCBL). This represents 40% of the P100 Million total capital infusion into MCBL with the balance of P60M to be provided by Manulife Philippines.

On top of complying with the higher capital requirements for insurance companies, the additional capital will improve MCBL's capacity to underwrite more business and enhance its competitive position.

Other Relevant Information

Please see attached.

Filed on behalf by:
Name CORAZON MORANDO
Designation VP & CORP. SEC.